Member presentation

LEK, d. d.

Lek is a part of Sandoz, the generic division of Novartis, and a pioneer in the field of biosimilars and the second-largest generic pharmaceutical company in the world. Novartis is the leading provider of medicines in Slovenia, where further development is planned, as well.

Besides being the leading development center of Sandoz, we are one of the key production sites for technologically demanding projects. Numerous innovative development projects are the result of our own knowledge and experience.

Lek, a Sandoz company, has been helping to create the development flow in the global pharmaceutical industry for 70 years now and has been steadily growing over these years.

Our pharmaceutical generic organization operates in Slovenia, Europe and worldwide. It focuses on connecting with customers and evolving the future. With the help of our knowledge, quality and experience we became one of the key pillars of Sandoz.

We develop, produce and distribute effective, safe and high-quality medicines, ranging from standard generics through modern biosimilar medicines. The foundation of our success is our knowledge, innovation, courage and care for our patients’ welfare.

We aim to build and preserve the reputation of a dynamic, ethical and trustworthy pharmaceutical company.

We operate within three development centers, namely:

  • global development center for products and technologies;
  • global development center for active pharmaceutical ingredients and medications,
  • global development center for biosimilars.

It was the competence and knowledge of our associates that placed us among the most important Sandoz global production centers for active pharmaceutical ingredients and medications.

Despite the increasingly restrictive economic and financial situation, Novartis continues to invest in Slovenia. In total, Novartis has invested more than 1.7 billion Euros in development, modernization and expansion of production over the past 13 years.

The cornerstone of our success is our knowledge. We heavily invest in development, education and training of our associates. For decades, we have been actively involved in progressing Slovenian research and development space. We have a well-established cooperation with Slovenian Universities and Centers of Excellence and we are very successful in linking economy with science.

We live quality every step of the way. Quality is an essential part of our daily work and relationships with our associates, patients and customers. For several years, it has been recognized by regulatory authorities worldwide.

High quality standards are met in all work processes, drug development and manufacture, as well as market supply with our highly qualified and experienced experts playing the key role.

We are proud to be the leading Sandoz company and introducing new products to the global markets.

Social act socially responsible. We believe that business success and social responsibility go hand in hand.

  • We strive to increase access to healthcare services, medicines and raise awareness on health issues.
  • We are a responsible and ethical employer and active community member.
  • We adopt a preventive approach, striving to make efficient use of natural resources and minimizing our environmental impact.
  • We operate in accordance with the highest standards of ethical business conduct.

As a Sandoz company, we would like to lead the generic pharmaceuticals industry and continuously set new higher quality standards. Our innovation agenda includes new drug delivery systems as well as very highly complex biosimilars.

Decades of experience and professional know-how are incorporated in the medications that we are manufacturing. Our investments in development are extensive and subject to strict international quality standards.

Contact details

LEK, d. d.
Verovškova 57, 1526 Ljubljana